First-Quarter 2022 First Quarter Overall Net Sales $720.0M | 7.4% Diluted Earnings Per Share: $2.29 | 15.1% Adjusted Diluted Earnings Per Share: $2.30| 12.2% WST Q1 2022 Earnings 1 "We delivered a solid first-quarter 2022 and remain on track to increase capacity throughout the year to satisfy the growing demand for our highvalue products (HVP)." "Our team members across the globe continue to demonstrate their passion to improve patient lives as they remain focused on executing our strategic initiatives desp ...

☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-8036 WEST PHARMACEUTICAL SERVICES, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) Common Stock, par value $.25 per share W ...

West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2021 Earnings Conference Call February 17, 2022 9:00 AM ET Company Participants Quintin Lai - VP-IR Eric Green - President and CEO Bernard Birkett - CFO Conference Call Participants Derik DeBruin - Bank of America Larry Solow - CJS Securities John Kreger - William Blair Jacob Johnson - Stephens Paul Knight - KeyBanc Capital Markets Dave Windley - Jefferies Operator Ladies and gentlemen thank you for standing by. And welcome to the Q4 2021 West Pharmaceutical ...

| --- | --- | --- | |-------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | West Pharmaceutical Services, Inc. | | | | Eric M. Green | | | | President & CEO | | | JP Morgan Conference | January 10, 2022 Safe Harbor Statement Cautionary Statement Under the Private Securities Litigation Reform Act of 1995 This presentation and any accompanying management commentary contain "forwardlooking statements" as that term is defined in the Private Securities Litigation Reform Act of 1 ...

Third-Quarter 2021 WST Q3 2021 Earnings 1 | --- | --- | --- | |----------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|----------| | Third Quarter Overall Net Sales $706.5M \| 28.9% | OVERALL ORGANIC SALES GROWTH Proprietary Products Q3 2021 organic sales growth of 35.7%, led by sales of high-value | Q3 27.9% | | Diluted Earnings Per Share: $2.31 \| ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-8036 WEST PHARMACEUTICAL SERVICES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 23-1210010 (State ...

West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2021 Earnings Conference Call October 28, 2021 9:00 AM ET Company Participants Quintin Lai – Vice President-Investor Relations Eric Green – President and Chief Executive Officer Bernard Birkett – Chief Financial Officer Conference Call Participants Larry Solow – CJS Securities John Kreger – William Blair Derik DeBruin – Bank of America Paul Knight – KeyBanc Dave Windley – Jefferies Operator Good day and thank you for standing by. Welcome to the Q3 2021 West P ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-8036 WEST PHARMACEUTICAL SERVICES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 23-1210010 (State or ot ...

West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2021 Earnings Conference Call July 29, 2021 9:00 AM ET Company Participants Quintin Lai - VP-IR Eric Green - CEO Bernard Birkett - CFO Conference Call Participants Paul Knight - KeyBanc Juan Avendano - Bank of America Larry Solow - CJS Securities Jacob Johnson - Stephens John Kreger - William Blair Dave Windley - Jefferies Operator Good day, and thank you for standing by. Welcome to the West Pharmaceutical Services Second Quarter 2021 Earnings Conference Call ...

West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2021 Earnings Conference Call April 29, 2021 9:00 AM ET Company Participants Quintin Lai - Vice President-Investor Relations Eric Green - Chief Executive Officer Bernard Birkett - Chief Financial Officer Conference Call Participants Juan Avendano - Bank of America Paul Knight - KeyBanc Jacob Johnson - Stephens Dave Windley - Jefferies Operator Good day and thank you for standing by. Welcome to the Q1 2021 West Pharmaceutical Services Earnings Conference Call. ...